PHOSPHATE BINDER THERAPY AND SERUM PHOSPHATE CONTROL FOLLOWING INITIATION OF HAEMODIALYSIS
Hyperphosphataemia is associated with increased all-cause mortality in patients with chronic kidney disease (CKD), but serum phosphate (P) levels can be managed by dialysis, diet and the use of P binders. Serum P data were obtained retrospectively from a US dialysis provider for the 9 months followi...
Saved in:
Main Authors: | Kimberly Farrand (Author), J Brian Copley (Author), Jamie Heise (Author), Moshe Fridman (Author), Michael Keith (Author), Arthur Silverberg (Author) |
---|---|
Format: | Book |
Published: |
The Korean Society of Nephrology,
2012-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RELATIVE DOSING OF PHOSPHATE BINDERS FOR EFFECTIVE MANAGEMENT OF PHOSPHATE AND PROTEIN INTAKE IN CHRONIC KIDNEY DISEASE
by: J Brian Copley, et al.
Published: (2012) -
DIETARY PHOSPHOROUS INTAKE AMONG HAEMODIALYSIS PATIENTS IN RELATION TO DOSAGE OF PHOSPHATE BINDERS AND HYPERPHOSPHATEMIA.
by: Camilla Cameron RD, et al.
Published: (2012) -
Effects of education on low-phosphate diet and phosphate binder intake to control serum phosphate among maintenance hemodialysis patients: A randomized controlled trial
by: Eunsoo Lim, et al.
Published: (2018) -
FERRIC CITRATE: AN IRON-BASED ORAL PHOSPHATE BINDER
by: T. Christopher Bond, et al.
Published: (2012) -
Ferric Citrate Hydrate as a Phosphate Binder and Risk of Aluminum Toxicity
by: Ajay Gupta
Published: (2014)